Genentech

Genentech

Posted via Workday

Global Clinical Trial Leader

Posted Oct 20, 2026

Role at a glance

Job function
Engineering & R&D Biotechnology & Pharmaceutical R&D
Salary
Not yet verified Check the description for pay details; an amount or pay period has not been verified.
Location
South San Francisco, United States
Work arrangement
Hybrid
Employment
Full-time
Experience
Bring 4+ years of clinical study management experience within biopharma or CRO environments. Demonstrate working knowledge of ICH/GCP guidelines, international regulatory frameworks, and early clinical drug development processes. Possess hands-on experience managing operational aspects of complex, global Phase I or Phase II clinical studies. Display proven expertise in clinical trial execution, cross-functional team collaboration, and study vendor oversight. Preferred Direct experience operating within oncology, immunology, infectious disease, or neuroscience early-phase clinical development. Demonstrated track record managing specialized vendors (central labs, specialty bioanalytical labs, imaging, interactive response technology/IRT) and decentralized/digital trial technologies. Proven ability to thrive in ambiguous, fast-paced environments requiring adaptive study designs and rapid protocol amendments.
Education
Hold a Bachelor’s degree or equivalent (scientific or healthcare discipline preferred).

Spotted an issue?

We’ll check it against the original posting.

Log in to report

Role Summary

AI-generated

The Global Clinical Trial Leader supports the operational execution and global delivery of early development Phase I and II clinical trials as part of cross-functional Protocol Execution Teams, under the leadership of the Senior CTL. The role provides operational expertise across study start-up, conduct, and close-out.

What You'll Do

  • Drive and finalize trial deliverables, including vendor specifications, investigational product drug supply forecasting, monitoring...
  • Collaborate with study teams on study plans, country and site feasibility assessments, and investigator meeting execution.
  • Participate in vendor identification and selection, and manage delegated outsourced CRO activities against contracted scope, timelines,...
  • Contribute operational feasibility insight to clinical protocol and informed consent document design.
  • Monitor critical path milestones, identify study risks, implement mitigation plans, and propose resolutions to trial bottlenecks.

Generated from the employer's posting. Verify important details before applying.

View full posting

Qualifications

Bachelor’s degree or equivalent. Requires 4+ years of clinical study management experience within biopharma or CRO environments, working knowledge of ICH/GCP guidelines, international regulatory frameworks, and early clinical drug development processes, and hands-on experience managing operational aspects of complex, global Phase I or Phase II clinical studies. Also requires expertise in clinical trial execution, cross-functional team collaboration, and study vendor oversight.

Preferred

  • Direct experience operating within oncology, immunology, infectious disease, or neuroscience early-phase clinical development.
  • Demonstrated track record managing specialized vendors (central labs, specialty bioanalytical labs, imaging, interactive response...
  • Proven ability to thrive in ambiguous, fast-paced environments requiring adaptive study designs and rapid protocol amendments.

Original job description

Content provided by the employer

Why Genentech


We’re passionate about delivering on Our Promise to improve the lives of patients and create healthier communities for all. We foster a culture of inclusivity, integrity and creativity while boldly pursuing answers to the world’s most complex health challenges and transforming society.


The Opportunity


As a Global Clinical Trial Leader (CTL) within Genentech Research and Early Development (gRED), you will be accountable for the operational execution and global delivery of pioneering early development clinical trials (Phases I and II) under the leadership of the Senior CTL. In this role, you will contribute directly to the cross-functional Protocol Execution Team (PET), translating cutting-edge scientific discoveries into highly flexible, operational reality for molecular entities with limited or no prior clinical data.

  • Provide clinical operational expertise across all study lifecycle phases (start-up, conduct, and close-out) to one or more global cross-functional Protocol Execution Teams (PETs).
  • Drive and finalize critical trial deliverables, including vendor specifications, investigational product drug supply forecasting, monitoring plans, Trial Master File (TMF) quality, and Clinical Trial Management System (CTMS) data integrity.
  • Collaborate with and influence multidisciplinary cross-functional study teams to solicit strategic input on study plans, country/site feasibility assessments, and investigator meeting execution.
  • Participate in vendor identification and selection alongside the PET Leader, managing delegated outsourced CRO activities to ensure deliverables align strictly with contracted scope, timelines, and budgets.
  • Contribute operational feasibility insight to the clinical protocol and informed consent document (ICF) design, anticipating operational challenges unique to early-stage human trials.
  • Monitor critical path study milestones, proactively identifying study risks, implementing mitigation plans, and proposing innovative resolutions to complex trial bottlenecks.
  • Foster an inclusive, high-trust, and accountable project environment across local and global cross-functional partners to ensure reliable, high-quality clinical trial delivery.

Who you are


  • Hold a Bachelor’s degree or equivalent (scientific or healthcare discipline preferred).
  • Bring 4+ years of clinical study management experience within biopharma or CRO environments.
  • Demonstrate working knowledge of ICH/GCP guidelines, international regulatory frameworks, and early clinical drug development processes.
  • Possess hands-on experience managing operational aspects of complex, global Phase I or Phase II clinical studies.
  • Display proven expertise in clinical trial execution, cross-functional team collaboration, and study vendor oversight.

Preferred


  • Direct experience operating within oncology, immunology, infectious disease, or neuroscience early-phase clinical development.
  • Demonstrated track record managing specialized vendors (central labs, specialty bioanalytical labs, imaging, interactive response technology/IRT) and decentralized/digital trial technologies.
  • Proven ability to thrive in ambiguous, fast-paced environments requiring adaptive study designs and rapid protocol amendments.

Location

  • This role is based in South San Francisco and offers a hybrid schedule working 3 day per week on campus
  • Relocation benefits are not available for this job posting

The expected salary range for this position based on the primary location of CA is $125,100.00 - $232,300.00 USD. Actual pay will be determined based on experience, qualifications, geographic location, and other job-related factors permitted by law. A discretionary annual bonus may be available based on individual and Company performance. This position also qualifies for the benefits detailed at the link provided below.

Benefits

Genentech is an equal opportunity employer. It is our policy and practice to employ, promote, and otherwise treat any and all employees and applicants on the basis of merit, qualifications, and competence. The company's policy prohibits unlawful discrimination, including but not limited to, discrimination on the basis of Protected Veteran status, individuals with disabilities status, and consistent with all federal, state, or local laws.

If you have a disability and need an accommodation in relation to the online application process, please contact us by completing this form Accommodations for Applicants.

Genentech

About the company

Genentech

Large Enterprise

Genentech, a member of the Roche Group, is a biotechnology company focused on discovering, developing, manufacturing, and commercializing innovative medicines for patients with serious medical conditions. Founded in 1976, Genentech has played a pioneering role in the biotech industry, particularly in the development of targeted therapies for cancer and other diseases. The company is committed to advancing science and addressing unmet medical needs through cutting-edge research and collaboration, making it a leader in the field of biotechnology. With a strong emphasis on sustainability and corporate responsibility, Genentech is dedicated to improving patient outcomes and enhancing healthcare globally.